Latest Leadership News

Pursuit Minerals has withdrawn its previously stated 5,000 tonnes per annum lithium production target, clarifying it was an aspirational figure not compliant with ASX rules. The company urges investors to avoid relying on this figure for investment decisions.

Invert Graphite has completed significant acquisitions including South Australian exploration licences and appointed a new CEO and board members, setting the stage for its next growth phase.

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.

Challenger Gold Limited has voluntarily suspended its ASX trading pending a significant capital raising announcement, signaling potential strategic moves ahead.

Elsight has landed a significant US$5.08 million contract with a European defence OEM, pushing its total 2025 orders from this customer to nearly US$14.7 million and signaling strong growth in unmanned systems connectivity.

Washington H. Soul Pattinson and Brickworks Limited have agreed to merge, creating a $14 billion ASX-listed entity and prompting key changes for Soul Patts' convertible notes. The deal simplifies their cross-shareholding and promises enhanced scale and diversification.

Lovisa Holdings has appointed John Cheston as Global CEO and Managing Director, alongside Mark McInnes as Executive Deputy Chairman, signaling a strategic push for global growth.

Adveritas Limited reports a record 61% increase in annualised recurring revenue, driven by strong gains in sports betting and new product launches, while preparing for a strategic expansion into North America.

Frontier Digital Ventures announces the resignation of CEO Shaun Di Gregorio effective November 2025, with co-founder Patrick Grove stepping in as Chairman immediately.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

AdAlta Limited has successfully raised $1.1 million through a renounceable rights issue, positioning itself to advance key CAR-T licensing and immunotherapy projects. The capital injection underscores confidence from leadership and investors amid a transformative phase for the biotech company.

Mont Royal Resources has announced the appointment of Nicholas Holthouse as President and CEO of Commerce Resources, setting the stage for their upcoming merger. Holthouse's extensive rare earths expertise is expected to drive the merged entity's growth in critical minerals.